Viridian Therapeutics所有資訊

Viridian Therapeutics | 10-Q：季度報表

05/08 07:53 (美東)

Viridian Therapeutics | 8-K：Viridian Therapeutics重點介紹近期進展並公佈2024年第一季度財務業績

05/08 07:13 (美東)

Viridian Therapeutics | ARS：年度報告

04/26 08:38 (美東)

Viridian Therapeutics | DEFA14A：其他

04/26 08:38 (美東)

Viridian Therapeutics | DEF 14A：股東委託書決議

04/26 08:33 (美東)

Viridian Therapeutics | 8-K：重大事件

04/16 16:11 (美東)

Viridian Therapeutics | SC 13D/A：超過5%持股股東披露文件(修正)-Fairmount Funds Management LLC(18.64%),Fairmount Healthcare Fund II GP LLC(18.64%)等

04/01 18:43 (美東)

Viridian Therapeutics | 4：持股變動聲明-董事 Fairmount Funds Management LLC

04/01 18:38 (美東)

Viridian Therapeutics | S-8：員工福利計劃證券登記

02/28 22:45 (美東)

Viridian Therapeutics | 10-K：年度報表

02/27 16:42 (美東)

Viridian Therapeutics | 8-K：Viridian Therapeutics重點介紹了近期進展並公佈了2023年第四季度和全年財務業績

02/27 16:17 (美東)

Viridian Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Venrock Healthcare Capital Partners III, L.P.(9.99%),VHCP Co-Investment Holdings III, LLC(9.99%)等

02/14 20:33 (美東)

Viridian Therapeutics | 3：首次持股聲明-高管 Tousignant Jennifer

02/14 18:06 (美東)

Viridian Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Commodore Capital LP(3.7%),Commodore Capital Master LP(3.7%)

02/14 18:05 (美東)

Viridian Therapeutics | 4：持股變動聲明-高管 Tousignant Jennifer

02/14 18:05 (美東)

Viridian Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)

02/14 17:53 (美東)

Viridian Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Biotechnology Value Fund, L.P.(0%),BVF I GP LLC(0%)等

02/14 09:27 (美東)

Viridian Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Deep Track Capital, LP(9.90%),Deep Track Biotechnology Master Fund, Ltd.(9.90%)等

02/14 09:02 (美東)

Viridian Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-The Vanguard Group(5.71%)

02/13 22:30 (美東)

Viridian Therapeutics | 4：持股變動聲明-高管 Ciulla Thomas

02/07 16:02 (美東)